Diabetic retinopathy is a leading cause of vision loss.
Recently co-authored this paper on a new potential therapeutic target…Investigational Plasma Kallikrein Inhibitors for the Treatment of Diabetic Macular Edema: An Expert Assessment
Recently co-authored this paper on a new potential therapeutic target…Investigational Plasma Kallikrein Inhibitors for the Treatment of Diabetic Macular Edema: An Expert Assessment
[ad_1] Just published…Diabetic macular edema, a leading cause of vision loss, is treated less intensely and shows worse outcomes than in clinical trials. More effective and longer acting therapies are needed. A Real-World Analysis of 28,658 Patient Eyes… https://t.co/4VaRq6BYQX [ad_2] Source by Thomas Ciulla, MD, …